Cx611-0204 SEPCELL Study

NCT03158727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Pneumonia

Interventions

BIOLOGICAL: Cx611
OTHER: Placebo

Sponsor

Tigenix S.A.U.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]